Genfit S.A. (EPA:GNFT)
 3.550
 -0.068 (-1.88%)
  Nov 3, 2025, 5:35 PM CET
Genfit Employees
Genfit had 180 employees as of December 31, 2024. The number of employees increased by 21 or 13.21% compared to the previous year.
Employees 
 180
Change (1Y) 
 21
Growth (1Y) 
 13.21%
Revenue / Employee 
 €240,027
Profits / Employee 
 €206,170
Market Cap 
176.77M
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 180 | 21 | 13.21% | 
| Dec 31, 2023 | 159 | 11 | 7.43% | 
| Dec 31, 2022 | 148 | 26 | 21.31% | 
| Dec 31, 2021 | 122 | -8 | -6.15% | 
| Dec 31, 2020 | 130 | -64 | -32.99% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Related Stocks
| Company Name | Employees | 
|---|---|
| EssilorLuxottica Société anonyme | 153,498 | 
| emeis Société anonyme | 83,494 | 
| Sanofi | 82,878 | 
| Eurofins Scientific SE | 62,696 | 
| Clariane SE | 61,798 | 
| bioMérieux | 14,754 | 
| Sartorius Stedim Biotech | 9,901 | 
| Virbac | 6,365 | 
Genfit News
- 4 days ago - Genfit (GNFT) Plans to Voluntarily Delist from Nasdaq - GuruFocus
 - 4 days ago - GENFIT to delist American depositary shares from Nasdaq - Seeking Alpha
 - 4 days ago - GENFIT announces intention to voluntarily delist American Depositary Shares from The Nasdaq Global Select Market - GlobeNewsWire
 - 6 days ago - GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting® 2025 - GlobeNewsWire
 - 25 days ago - Viking Therapeutics, Genfit, Sagimet jump as Novo to buy Akero - Seeking Alpha
 - 5 weeks ago - Genfit (GNFT): HC Wainwright & Co. Lowers Price Target To $7.00 | GNFT Stock News - GuruFocus
 - 6 weeks ago - Genfit (GNFTF) Reports 41.7% Revenue Decline in First Half of 2025 - GuruFocus
 - 6 weeks ago - Genfit S.A. GAAP EPS of -€0.20, revenue of €35.67M - Seeking Alpha